Surgery Partners, Inc.

Historical 13F Holders

Symbol
SGRY
CUSIP
86881A100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 86881A100 since 12/18/2024, largest first.

Filer % of Class Filed
BCPE Seminole Holdings LP 13D/A
23.5% 6/17/2025
Event 6/16/2025
Janus Henderson Group PLC 13G/A
10.2% 11/14/2025
Event 9/30/2025
Pentwater Capital Management LP 13G/A
9.7% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
King Street Capital Management, L.P. 13G
4.6% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G/A 4.4% 4/29/2025
Event 3/31/2025
FMR LLC 13G/A
1.7% 5/6/2026
Event 3/31/2026
Wellington Management Group LLP 13G/A
0% 8/12/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 5 954 $13.2 k
2026 Q2 199 160 M $2.75 B
2026 Q1 195 159 M $1.90 B
2025 Q4 195 159 M $2.46 B
2025 Q3 222 152 M $3.28 B
2025 Q2 226 144 M $3.21 B
2025 Q1 228 140 M $3.34 B
2024 Q4 198 142 M $3.00 B
2024 Q3 203 138 M $4.45 B
2024 Q2 195 143 M $3.39 B
2024 Q1 198 138 M $4.11 B
2023 Q4 189 137 M $4.37 B
2023 Q3 177 135 M $3.94 B
2023 Q2 179 133 M $5.98 B
2023 Q1 158 130 M $2.48 B
2022 Q4 174 130 M $3.62 B
2022 Q3 145 93.9 M $2.20 B
2022 Q2 143 92.4 M $2.67 B
2022 Q1 162 90.7 M $4.99 B
2021 Q4 155 88.4 M $4.72 B
2021 Q3 153 81.1 M $3.43 B
2021 Q2 152 80.6 M $5.37 B
2021 Q1 135 57.6 M $2.62 B
2020 Q4 129 49.3 M $1.43 B
2020 Q3 111 47.5 M $1.04 B
2020 Q2 105 48.2 M $558 M
2020 Q1 90 47.1 M $307 M
2019 Q4 103 45.9 M $721 M
2019 Q3 93 48.3 M $356 M
2019 Q2 96 47.8 M $389 M
2019 Q1 87 48.0 M $542 M
2018 Q4 84 47.8 M $468 M
2018 Q3 88 47.6 M $786 M
2018 Q2 85 47.8 M $712 M
2018 Q1 92 48.1 M $824 M
2017 Q4 88 49.4 M $598 M
2017 Q3 93 46.3 M $479 M
2017 Q2 91 18.7 M $424 M
2017 Q1 89 19.0 M $370 M
2016 Q4 96 18.2 M $288 M
2016 Q3 89 18.7 M $378 M
2016 Q2 90 18.7 M $335 M
2016 Q1 65 17.3 M $230 M
2015 Q4 66 16.3 M $333 M